Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion

BACKGROUND: Clinically, prophylactic anti-recurrence treatments for hepatocellular carcinoma (HCC) patients after radical surgery are extremely limited. Neoantigen based vaccine can generate robust anti-tumor immune response in several solid tumors but whether it could induce anti-tumor immune respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Zhixiong, Su, Xiaoping, Qiu, Liman, Li, Zhenli, Li, Xiaolou, Dong, Xiuqing, Wei, Fuqun, Zhou, Yang, Luo, Liuping, Chen, Geng, Chen, Hengkai, Wang, Yingchao, Zeng, Yongyi, Liu, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667400/
https://www.ncbi.nlm.nih.gov/pubmed/34903219
http://dx.doi.org/10.1186/s12943-021-01467-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667400/
https://www.ncbi.nlm.nih.gov/pubmed/34903219
http://dx.doi.org/10.1186/s12943-021-01467-8

Ejemplares similares